This is a link to the study parameters and the 8 U.S. academic medical center participants. The study began in August 2021, is seeking 100 patients, and expects to finish September 2022.
https://clinicaltrials.gov/ct2/show/NCT04996264
Press release by Ophirex, the sponsoring company - inventor of the snakebite oral pill. Fascinating approach.
https://www.ophirex.com/20220314-oph...-for-snakebite
Reply With Quote